MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer

Cancer Science

Volumn 105, Issue 8, 2014, Pages 956-965

  Zhou, Huading ^a   Guo, Weijie ^b,c   Zhao, Yingjun ^c   Wang, Yifei ^a   Zha, Ruopeng ^c   Ding, Jie ^c   Liang, Linhui ^c   Yang, Guanghua ^a   Chen, Zongyou ^a   Ma, Baojin ^a   Yin, Baobing ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gallbladder cancer; MiR 135a; P38; Proliferation; Very low density lipoprotein receptor

Indexed keywords

MICRORNA; MICRORNA 135A; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; GALLBLADDER CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

GALLBLADDER CANCER; MIR-135A; P38; PROLIFERATION; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

AGED; BLOTTING, WESTERN; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84906535280     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12463     Document Type: Article

References (21)

1. Chen YL, Huang ZQ, Zhou NX et al. Clinical analysis of 110 patients with primary gallbladder carcinoma. Zhonghua Zhong Liu Za Zhi 2007; 29: 704-6.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33.
4. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
5. Friedman RC, Farh KK, Burge CB et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
6. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
7. Calin GA, Sevignani C, Dumitru CD et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999-3004.
8. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31.
9. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432: 226-30.
10. Zhang B, Pan X, Cobb GP et al. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
11. Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 2010; 192: 275-83.
12. Nakamura Y, Yamamoto M, Kumamaru E. Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells. Arch Pathol Lab Med 2000; 124: 119-22.
13. Navarro A, Diaz T, Martinez A et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 2009; 114: 2945-51.
14. Wu H, Huang M, Cao P et al. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Cancer Biol Ther 2012; 13: 281-8.
15. Yamada Y, Hidaka H, Seki N et al. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci 2013; 104: 304-12.
16. Wu S, Lin Y, Xu D et al. MiR-135a functions as a selective killer of malignant glioma. Oncogene 2012; 31: 3866-74.
17. Zhou L, Qiu T, Xu J et al. miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1. Pathol Oncol Res 2013; 19: 677-83.
18. Holleman A, Chung I, Olsen RR et al. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene 2011; 30: 4386-98.
19. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995; 9: 890-8.
20. Martensen PM, Oka K, Christensen L et al. Breast carcinoma epithelial cells express a very low-density lipoprotein receptor variant lacking the O-linked glycosylation domain encoded by exon 16, but with full binding activity for serine proteinase/serpin complexes and Mr-40, 000 receptor-associated protein. Eur J Biochem 1997; 248: 583-91.
21. Rebustini IT, Hayashi T, Reynolds AD et al. miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. Development 2012; 139: 191-202.